236 related articles for article (PubMed ID: 15554959)
1. Protein-protein interactions within the Fatty Acid Synthase-II system of Mycobacterium tuberculosis are essential for mycobacterial viability.
Veyron-Churlet R; Guerrini O; Mourey L; Daffé M; Zerbib D
Mol Microbiol; 2004 Dec; 54(5):1161-72. PubMed ID: 15554959
[TBL] [Abstract][Full Text] [Related]
2. The biosynthesis of mycolic acids in Mycobacterium tuberculosis relies on multiple specialized elongation complexes interconnected by specific protein-protein interactions.
Veyron-Churlet R; Bigot S; Guerrini O; Verdoux S; Malaga W; Daffé M; Zerbib D
J Mol Biol; 2005 Nov; 353(4):847-58. PubMed ID: 16213523
[TBL] [Abstract][Full Text] [Related]
3. The missing piece of the type II fatty acid synthase system from Mycobacterium tuberculosis.
Sacco E; Covarrubias AS; O'Hare HM; Carroll P; Eynard N; Jones TA; Parish T; Daffé M; Bäckbro K; Quémard A
Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14628-33. PubMed ID: 17804795
[TBL] [Abstract][Full Text] [Related]
4. Development of a scintillation proximity assay for the Mycobacterium tuberculosis KasA and KasB enzymes involved in mycolic acid biosynthesis.
Schaeffer ML; Carson JD; Kallender H; Lonsdale JT
Tuberculosis (Edinb); 2004; 84(6):353-60. PubMed ID: 15525558
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of MabA from Mycobacterium tuberculosis, a reductase involved in long-chain fatty acid biosynthesis.
Cohen-Gonsaud M; Ducasse S; Hoh F; Zerbib D; Labesse G; Quemard A
J Mol Biol; 2002 Jul; 320(2):249-61. PubMed ID: 12079383
[TBL] [Abstract][Full Text] [Related]
6. Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis.
Slayden RA; Lee RE; Barry CE
Mol Microbiol; 2000 Nov; 38(3):514-25. PubMed ID: 11069675
[TBL] [Abstract][Full Text] [Related]
7. Structure-function analysis of the acyl carrier protein synthase (AcpS) from Mycobacterium tuberculosis.
Dym O; Albeck S; Peleg Y; Schwarz A; Shakked Z; Burstein Y; Zimhony O
J Mol Biol; 2009 Nov; 393(4):937-50. PubMed ID: 19733180
[TBL] [Abstract][Full Text] [Related]
8. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
9. MabA (FabG1), a Mycobacterium tuberculosis protein involved in the long-chain fatty acid elongation system FAS-II.
Marrakchi H; Ducasse S; Labesse G; Montrozier H; Margeat E; Emorine L; Charpentier X; Daffé M; Quémard AK
Microbiology (Reading); 2002 Apr; 148(Pt 4):951-960. PubMed ID: 11932442
[TBL] [Abstract][Full Text] [Related]
10. Crystallographic and pre-steady-state kinetics studies on binding of NADH to wild-type and isoniazid-resistant enoyl-ACP(CoA) reductase enzymes from Mycobacterium tuberculosis.
Oliveira JS; Pereira JH; Canduri F; Rodrigues NC; de Souza ON; de Azevedo WF; Basso LA; Santos DS
J Mol Biol; 2006 Jun; 359(3):646-66. PubMed ID: 16647717
[TBL] [Abstract][Full Text] [Related]
11. Product diversity and regulation of type II fatty acid synthases.
Lu YJ; Zhang YM; Rock CO
Biochem Cell Biol; 2004 Feb; 82(1):145-55. PubMed ID: 15052334
[TBL] [Abstract][Full Text] [Related]
12. Mycolic acid biosynthesis and enzymic characterization of the beta-ketoacyl-ACP synthase A-condensing enzyme from Mycobacterium tuberculosis.
Kremer L; Dover LG; Carrère S; Nampoothiri KM; Lesjean S; Brown AK; Brennan PJ; Minnikin DE; Locht C; Besra GS
Biochem J; 2002 Jun; 364(Pt 2):423-30. PubMed ID: 12023885
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium tuberculosis beta-ketoacyl acyl carrier protein synthase III (mtFabH) assay: principles and method.
Sachdeva S; Reynolds KA
Methods Mol Med; 2008; 142():205-13. PubMed ID: 18437316
[TBL] [Abstract][Full Text] [Related]
14. The condensing activities of the Mycobacterium tuberculosis type II fatty acid synthase are differentially regulated by phosphorylation.
Molle V; Brown AK; Besra GS; Cozzone AJ; Kremer L
J Biol Chem; 2006 Oct; 281(40):30094-103. PubMed ID: 16873379
[TBL] [Abstract][Full Text] [Related]
15. Purification and biochemical characterization of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthases KasA and KasB.
Schaeffer ML; Agnihotri G; Volker C; Kallender H; Brennan PJ; Lonsdale JT
J Biol Chem; 2001 Dec; 276(50):47029-37. PubMed ID: 11600501
[TBL] [Abstract][Full Text] [Related]
16. Binding of the tautomeric forms of isoniazid-NAD adducts to the active site of the Mycobacterium tuberculosis enoyl-ACP reductase (InhA): a theoretical approach.
Stigliani JL; Arnaud P; Delaine T; Bernardes-Génisson V; Meunier B; Bernadou J
J Mol Graph Model; 2008 Nov; 27(4):536-45. PubMed ID: 18955002
[TBL] [Abstract][Full Text] [Related]
17. The Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III activity is inhibited by phosphorylation on a single threonine residue.
Veyron-Churlet R; Molle V; Taylor RC; Brown AK; Besra GS; Zanella-Cléon I; Fütterer K; Kremer L
J Biol Chem; 2009 Mar; 284(10):6414-24. PubMed ID: 19074144
[TBL] [Abstract][Full Text] [Related]
18. Crystallographic studies on the binding of isonicotinyl-NAD adduct to wild-type and isoniazid resistant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis.
Dias MV; Vasconcelos IB; Prado AM; Fadel V; Basso LA; de Azevedo WF; Santos DS
J Struct Biol; 2007 Sep; 159(3):369-80. PubMed ID: 17588773
[TBL] [Abstract][Full Text] [Related]
19. Characterization and site-directed mutagenesis of the putative novel acyl carrier protein Rv0033 and Rv1344 from Mycobacterium tuberculosis.
Huang Y; Ge J; Yao Y; Wang Q; Shen H; Wang H
Biochem Biophys Res Commun; 2006 Apr; 342(2):618-24. PubMed ID: 16487939
[TBL] [Abstract][Full Text] [Related]
20. Selection of an Escherichia coli host that expresses mutant forms of Mycobacterium tuberculosis 2-trans enoyl-ACP(CoA) reductase and 3-ketoacyl-ACP(CoA) reductase enzymes.
Poletto SS; da Fonseca IO; de Carvalho LP; Basso LA; Santos DS
Protein Expr Purif; 2004 Mar; 34(1):118-25. PubMed ID: 14766307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
